Recognition of losses related to the novel infectious disease
First written in FY2021-Q1. 5 of 7 entries say "Restated". Latest entry: FY2022.
1 other company's latest entry also says "Restated".
- FY2022RestatedAnnual report
「Losses related to the novel infectious disease 581 －」
The full-year financial statements confirmed that the ¥581 million in losses related to the novel infectious disease recognized in the previous fiscal year was not recognized in the current consolidated fiscal year. - FY2022-Q3RestatedAnnual report
「Losses related to the novel infectious disease 581 －」
The ¥581 million in losses related to the novel infectious disease recognized in the same period of the previous year was not recognized in the cumulative period through the current third quarter. - FY2022-Q1None recorded for the periodAnnual report
「Losses related to the novel infectious disease 581 －」
The ¥581 million in losses related to the novel infectious disease recognized in the same period of the previous year was not recognized in the current quarter. - FY2021RestatedAnnual report
「As a result of recognizing ¥581 million in losses related to the novel infectious disease as extraordinary losses, among other factors, net income attributable to owners of the parent was ¥25,329 million, up 6.9% year on year.」
The recognition of ¥581 million in losses related to the novel infectious disease was also disclosed in the full-year results. - FY2021-Q3RestatedAnnual report
「The company recognized as extraordinary losses the losses incurred during the first quarter from temporary store closures and other measures taken to prevent the spread of COVID-19 amid declarations of a state of emergency and requests from the national and local governments to suspend business operations. The breakdown is as follows. Fixed costs related to stores (rent) ¥432 million Employee salaries and allowances (special support payments) ¥126 million Infection-prevention costs ¥22 million Total ¥581 million」
The extraordinary loss of ¥581 million and its breakdown, arising from temporary store closures and other measures to prevent the spread of the novel infectious disease, continued to be disclosed. - FY2021-Q2RestatedAnnual report
「The Group recognized as extraordinary losses the losses incurred from temporary store closures and other measures taken to prevent the spread of COVID-19. The breakdown is as follows. Fixed costs related to stores (rent) ¥432 million Employee salaries and allowances (special support payments) ¥126 million Infection-prevention costs ¥22 million Total ¥581 million」
¥581 million in losses related to the novel infectious disease arising from temporary store closures and other measures, together with the breakdown, continued to be recognized in the financial statements. - FY2021-Q1First statedAnnual report
「The Group recognized as extraordinary losses the losses incurred from temporary store closures and other measures taken to prevent the spread of COVID-19 amid declarations of a state of emergency and requests from the national and local governments to suspend business operations. The breakdown is as follows. Fixed costs related to stores (rent) ¥432 million Employee salaries and allowances (special support payments) ¥126 million Infection-prevention costs ¥22 million Total ¥581 million」
The company recognized ¥581 million in extraordinary losses for temporary store closures and other losses associated with declarations of a state of emergency and requests to suspend business operations.